Sothema Group, Moroccos leading pharmaceutical company led by Lamia Tazi is preparing for one of its most ambitious moves yet as it looks to acquire the assets linked to the CIALIS brand from U.S. drugmaker Eli Lilly, the nearly 1 trillion pharmaceutical giant.
Sothema strengthens specialized therapy offerings
The move, now going through formal approval, centers on the rights tied to the erectile-dysfunction medication rather than the company behind it. If cleared, the deal would give Sothema a product with global recognition and deepen its reach in a competitive market.
